EpiEndo Pharmaceuticals Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
9
- Latest Deal Type
-
Series B
- (Upcoming)
- Latest Deal Amount
-
$175M
- Investors
-
7
EpiEndo Pharmaceuticals General Information
Description
Developer of therapeutics designed to treat chronic respiratory and inflammatory disorders by improving epithelial function and host defense mechanisms. The company offers orally available macrolide-derived compounds with reduced antimicrobial resistance potential and anti-inflammatory properties, enabling patients with chronic respiratory and inflammatory conditions to reduce disease exacerbations and improve immune response to inhaled pathogens.
Contact Information
Website
www.epiendo.comCorporate Office
- Kristínargata 1
- Reykjavik, 102
- Iceland
Corporate Office
- Kristínargata 1
- Reykjavik, 102
- Iceland
EpiEndo Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 13. Later Stage VC (Series B) | $175M | Upcoming | Clinical Trials - Phase 2 | |||
| 12. Later Stage VC | 07-Jan-2026 | Completed | Clinical Trials - Phase 2 | |||
| 11. Later Stage VC (Series A) | 01-Sep-2022 | Completed | Clinical Trials - Phase 2 | |||
| 10. Later Stage VC | 15-Apr-2021 | Completed | Clinical Trials - Phase 2 | |||
| 9. Seed Round | 19-Dec-2019 | Completed | Clinical Trials - Phase 2 | |||
| 8. Grant | 09-Oct-2019 | Completed | Clinical Trials - Phase 2 | |||
| 7. Seed Round | 17-Jan-2019 | Completed | Clinical Trials - Phase 2 | |||
| 6. Grant | 29-Jun-2018 | Completed | Startup | |||
| 5. Grant | 31-Jan-2017 | Completed | Startup | |||
| 4. Seed Round | 20-Sep-2016 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
EpiEndo Pharmaceuticals Patents
EpiEndo Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202416444-D0 | Compounds | Inactive | 07-Nov-2024 | ||
| GB-202413660-D0 | Compounds | Inactive | 17-Sep-2024 | ||
| WO-2026041802-A1 | Azithromycin derivatives for use in the treatment of infections | Pending | 23-Aug-2024 | ||
| GB-202412461-D0 | Medial use | Inactive | 23-Aug-2024 | ||
| GB-202404587-D0 | Chemical forms | Inactive | 28-Mar-2024 | C07H17/08 |
EpiEndo Pharmaceuticals Signals
EpiEndo Pharmaceuticals Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Flerie | Venture Capital | Minority | ||
| InfoCapital | Venture Capital | Minority | ||
| Kvika Framtak | PE/Buyout | Minority | ||
| Tunga fjárfestingafélag | Family Office | Minority | ||
| European Innovation Council | Accelerator/Incubator | Minority |
EpiEndo Pharmaceuticals FAQs
-
When was EpiEndo Pharmaceuticals founded?
EpiEndo Pharmaceuticals was founded in 2014.
-
Where is EpiEndo Pharmaceuticals headquartered?
EpiEndo Pharmaceuticals is headquartered in Reykjavik, Iceland.
-
What is the size of EpiEndo Pharmaceuticals?
EpiEndo Pharmaceuticals has 9 total employees.
-
What industry is EpiEndo Pharmaceuticals in?
EpiEndo Pharmaceuticals’s primary industry is Drug Discovery.
-
Is EpiEndo Pharmaceuticals a private or public company?
EpiEndo Pharmaceuticals is a Private company.
-
What is EpiEndo Pharmaceuticals’s current revenue?
The current revenue for EpiEndo Pharmaceuticals is .
-
How much funding has EpiEndo Pharmaceuticals raised over time?
EpiEndo Pharmaceuticals has raised $37.1M.
-
Who are EpiEndo Pharmaceuticals’s investors?
Flerie, InfoCapital, Kvika Framtak, Tunga fjárfestingafélag, and European Innovation Council are 5 of 7 investors who have invested in EpiEndo Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process